Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Matthew P. Young files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Sean A. McCarthy - $1.23M in CTMX purchases and sales in the last 12 months
- Marcia Belvin - $202K in CTMX purchases and sales in the last 12 months
- Yu-Waye Chu - $137K in CTMX purchases and sales in the last 12 months
- Christopher Ogden - $129K in CTMX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Matthew P. Young?
Matthew P. Young is a corporate insider of CytomX Therapeutics, Inc. (CTMX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Matthew P. Young last file a Form 4?
The only primary Form 4 on record is dated 22 June 2026.